ABC-06  (2nd line chemotherapy trial)

Please note: The ABC-06 trial met its recruitment target of 162 patients on 5th January, 2018, and so is no longer recruiting new patients.

The ABC-06 trial is open at a number of centres in the UK.  You can find more details and information about eligibility here:
http://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/a-trial-looking-at-oxaliplatin-and-5fu-for-advanced-biliary-tract-cancers-abc06

and here:
https://clinicaltrials.gov/ct2/show/NCT01926236

Lead investigator on the ABC-06 trial:
Professor Juan Valle
Professor of Medical Oncology The Christie, Manchester

Direct e-mail: juan.valle@christie.nhs.uk
PA: Lindsey Duncan:
Tel 0161 446 8106
Fax 0161 446 3468
e-mail: lindsey.duncan@christie.nhs.uk

The Christie
Department of Medical Oncology
The Christie NHS Foundation Trust
Wilmslow Road
Manchester    M20 4BX

Please Note: Patients taking part in either arm of the 2nd line ABC-06 trial may also participate in relevant Phase I trials, if eligible.* (For those patients in the chemotherapy arm, at least 28 days after their last chemotherapy treatment should be allowed.) This should be done in consultation with the ABC-06 trial office.

*See the ABC-06 trial protocol “4.2.3.-Concomitant medication”

Back to previous page